Commonwealth Equity Services, LLC Vista Gen Therapeutics, Inc. Transaction History

Commonwealth Equity Services, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$0.12 - $0.3 $120 - $300	1,000 Added 5.23%	20,111 $2,000
Q4 2022 Feb 07, 2023	SELL	$0.09 - $0.16 $900 - $1,600	-10,000 Reduced 34.35%	19,111 $1,000
Q3 2022 Nov 14, 2022	BUY	$0.14 - $1.07 $1,073 - $8,202	7,666 Added 35.75%	29,111 $4,000
Q2 2022 Jul 19, 2022	BUY	$0.88 - $1.73 $660 - $1,297	750 Added 3.62%	21,445 $18,000
Q4 2021 Jan 31, 2022	SELL	$1.67 - $2.76 $4,742 - $7,838	-2,840 Reduced 12.07%	20,695 $40,000

Q2 2021 Aug 11, 2021	BUY	$1.96 - $3.15 $10,466 - $16,821	5,340 Added 29.35%	23,535 $74,000
Q1 2021 May 04, 2021	BUY	$1.89 - $2.96 $34,388 - $53,857	18,195 New	18,195 $38,000
Q4 2020 Feb 11, 2021	SELL	$0.65 - $1.94 $8,576 - $25,598	-13,195 Closed	0 $0
Q3 2019 Oct 30, 2019	BUY	$0.46 - $1.29 $6,069 - $17,021	13,195 New	13,195 $14,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $720M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.